Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China

Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China

Objective To evaluate the cost-effectiveness of the current strategy combining universal vaccination with hepatitis B immunoglobulin (HBIG) treatment for infants of hepatitis B surface antigen (HBsAg) positive mothers compared with universal vaccination with hepatitis B vaccine only. Methods A decis...

Full description

Bibliographic Details
Main Authors: Yanbing Zeng, Mingliang Luo, Jianlin Lin, Hanqing He, Xuan Deng, Shuyun Xie, Ya Fang
Format: Article
Language:English
Published: Taylor & Francis Group 2020-04-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
hepatitis b
mother-to-child
infection
cost-effectiveness
qaly
Online Access:http://dx.doi.org/10.1080/21645515.2019.1688031

Internet

http://dx.doi.org/10.1080/21645515.2019.1688031

Similar Items